17,261 trials
Down Syndrome · Amyloid Beta-protein
Primary: Sensitivity of the Independent Visual Assessment of Detecting Cerebral Amyloid-beta in Individuals With Down Syndrome and Specificity in Subjects Without Down Syndrome…
Hepatitis · Hepatitis C
Primary: Percentage of Participants With Sustained Viral Response (SVR) at Week 72 — 41.7; 39.6; 45.8 percentage of participants
Kidney Cancer
Primary: Number of Patients With Ani-tumor Activity After Taking OSI-774. — 7 participants
Previously Treated Childhood Rhabdomyosarcoma · Recurrent Childhood Rhabdomyosarcoma · Recurrent Childhood Soft Tissue Sarcoma
Primary: Response (Complete Response [CR] and Partial Response [PR]) — 1; 0; 0; 0 participants
Recurrent Melanoma · Stage IIA Melanoma · Stage IIB Melanoma
Primary: Objective Response Rate — 0 percentage of participants
Human Influenza
Primary: Percentages of Subjects Who Achieved Seroconversion or Significant Increase in SRH Area Against Each of Three Vaccine Strains After One Vaccination of aTIV — 59; 65; 81…
Prostate Cancer
Primary: To Determine the Proportion of Patients With Metastatic CRPC Who do Not Have Prostate Specific Antigen (PSA) Progression After 24 Weeks of Therapy With One of Two…
HIV-1
Primary: Percentage of Participants With Less Than 50 Copies Per Milliliter (Copies/mL) of Human Immunodeficiency Virus Type 1 Ribonucleic Acid (HIV-1 RNA) at Week 48 — 78.5…
Glioma
Primary: Number of Participants With DLT- Phase I — 2; 0; 4 participants
Solid Tumor
Primary: The Difference in the Change From Baseline (Predose on Day 1) in QTc Intervals Trabectedin Relative to Placebo at 24 Hour Post Dose by Fridericia Correction — 3.6; -6.2…
Squamous Cell Carcinoma
Primary: Response Rate to Induction Chemotherapy Prior to Definitive Therapy (Surgery or Radiation) — 32 participants
Recurrent Mantle Cell Lymphoma
Primary: Overall Response Rate (Complete and Partial Responses) as Defined by the International Workshop Criteria — 62.5; 52.4 percentage of patients
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma · Recurrent Metastatic Squamous Neck Cancer With Occult Primary · Recurrent Squamous Cell Carcinoma of the Hypopharynx
Primary: Objective Tumor Response Rate (Complete Response [CR] and Partial Response [PR]) Using RECIST Criteria — 6.7; 0 percentage of participants
Recurrent Melanoma · Stage IV Cutaneous Melanoma AJCC v6 and v7
Primary: Tumor Response Rate — 7.7 percentage of patients
Adenocarcinoma of the Gastroesophageal Junction · Diffuse Adenocarcinoma of the Stomach · Intestinal Adenocarcinoma of the Stomach
Primary: Overall Response Rate — 1; 0; 4; 1 participants